SOCS-1 Participates in Negative Regulation of LPS Responses

Slides:



Advertisements
Similar presentations
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Advertisements

Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Volume 25, Issue 2, Pages (August 2006)
Volume 9, Issue 5, Pages (November 1998)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Regulation of Mast Cell Survival by IgE
Volume 133, Issue 5, Pages (November 2007)
Volume 25, Issue 6, Pages (December 2006)
CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages.
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
Volume 45, Issue 5, Pages (November 2016)
Volume 31, Issue 2, Pages (August 2009)
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Volume 24, Issue 5, Pages (May 2006)
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing.
LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia by Hongwei Qin, Cynthia A. Wilson, Sun Jung Lee,
Human osteoarthritic chondrocytes are impaired in matrix metalloproteinase-13 inhibition by IFN-γ due to reduced IFN-γ receptor levels  R. Ahmad, M. El.
Volume 132, Issue 1, Pages (January 2007)
Volume 26, Issue 1, Pages (January 2007)
Volume 30, Issue 3, Pages (March 2009)
Volume 11, Issue 4, Pages (October 1999)
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Volume 38, Issue 4, Pages (April 2013)
Volume 26, Issue 2, Pages (February 2007)
Volume 47, Issue 5, Pages e6 (November 2017)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 42, Issue 4, Pages (April 2015)
Volume 29, Issue 4, Pages (October 2008)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Volume 125, Issue 1, Pages (July 2003)
Volume 132, Issue 5, Pages (May 2007)
Volume 27, Issue 2, Pages (August 2007)
Regulation of Mast Cell Survival by IgE
Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1  Cao-Qi Lei, Bo Zhong, Yu.
Volume 37, Issue 2, Pages (August 2012)
Volume 10, Issue 1, Pages (January 1999)
Volume 14, Issue 5, Pages (May 2001)
Volume 22, Issue 2, Pages (February 2005)
Volume 19, Issue 5, Pages (November 2003)
Volume 19, Issue 3, Pages (September 2003)
Volume 61, Issue 6, Pages (June 2002)
Volume 32, Issue 4, Pages (April 2010)
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Volume 24, Issue 3, Pages (March 2006)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Volume 21, Issue 6, Pages (November 2017)
Volume 29, Issue 5, Pages (November 2008)
Silva H Hanissian, Raif S Geha  Immunity 
Volume 57, Issue 2, Pages (October 2000)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 33, Issue 5, Pages (November 2010)
Volume 4, Issue 3, Pages (September 2008)
TWEAK Attenuates the Transition from Innate to Adaptive Immunity
Volume 27, Issue 4, Pages (October 2007)
Volume 38, Issue 1, Pages (January 2013)
Volume 31, Issue 6, Pages (December 2009)
Heterozygous N-terminal deletion of IκBα results in functional nuclear factor κB haploinsufficiency, ectodermal dysplasia, and immune deficiency  Douglas.
Volume 11, Issue 3, Pages (September 1999)
Volume 137, Issue 6, Pages e2 (December 2009)
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Volume 24, Issue 1, Pages (January 2006)
Volume 129, Issue 5, Pages (June 2007)
Volume 12, Issue 6, Pages (March 2002)
Volume 10, Issue 2, Pages (February 1999)
Volume 25, Issue 3, Pages (September 2006)
Volume 13, Issue 21, Pages (October 2003)
Presentation transcript:

SOCS-1 Participates in Negative Regulation of LPS Responses Reiko Nakagawa, Tetsuji Naka, Hiroko Tsutsui, Minoru Fujimoto, Akihiro Kimura, Tatsuo Abe, Ekihiro Seki, Shintaro Sato, Osamu Takeuchi, Kiyoshi Takeda, Shizuo Akira, Koichi Yamanishi, Ichirou Kawase, Kenji Nakanishi, Tadamitsu Kishimoto  Immunity  Volume 17, Issue 5, Pages 677-687 (November 2002) DOI: 10.1016/S1074-7613(02)00449-1

Figure 1 Hypersensitivity of SOCS-1 KO Mice to LPS In Vivo (Aa) Three-day-old SOCS-1 KO and littermate WT mice were i.p. administered with 0, 5, or 50 μg LPS. Survival was monitored until 12 hr after LPS challenge. SOCS-1 KO mice showed lower survival than WT mice upon challenge with 5 μg (p < 0.01) or 50 μg LPS (p < 0.01). (Ab) Four-week-old SOCS-1 He and littermate WT mice were i.p. administered with 0, 300, or 500 μg LPS. Survival was monitored until 72 hr after LPS challenge. SOCS-1 He mice showed lower survival than WT mice upon challenge with 5 μg (p < 0.01) or 50 μg LPS (p < 0.01). (Ba) Serum TNF-α levels from SOCS-1 KO or littermate WT mice (3-day-old) were measured at 0 and 2 hr after intraperitoneal injection of LPS (50 μg). (Bb) Serum TNF-α levels from SOCS-1 He or littermate WT mice (4-week-old) were measured at 0 and 2 hr after intraperitoneal injection of LPS (500 μg). Data in (Aa) and (Ab) represent 15 mice in each experimental group and are the result of two independent experiments with similar results. Data in (Ba) and (Bb) show the mean ± SD for three mice from each group and are representative of three independent experiments with similar results. Immunity 2002 17, 677-687DOI: (10.1016/S1074-7613(02)00449-1)

Figure 2 Hyperresponse to LPS of SOCS-1-Deficient Macrophages (A, B, C, and E) Splenic adherent cells isolated from mice with various genotypes were primed with different amount of LPS (A, B, and E) or CpG DNA (C) for 12 hr, after which culture supernatants were harvested for measurement of TNF-α (A and E) or IL-12p40 (B and C). (D) The same splenic adherent cells from the mice with various genotypes were incubated with FITC-conjugated anti-I-A, anti-CD40, anti-CD80, anti-CD86, or a combination of PE-conjugated streptavidin, biotinylated anti-rat IgG2b, and anti-F4/80. The cell yield of SOCS-1 KO mice was (2.3 ± 0.8) × 105/mouse, while that of WT was (2.0 ± 1.3) × 105/mouse. Data in (A)–(E) are representative of three independent experiments with similar results. ND, not detected. Immunity 2002 17, 677-687DOI: (10.1016/S1074-7613(02)00449-1)

Figure 3 Essential Role of SOCS-1 in Induction of LPS Tolerance (Aa) Three-day-old SOCS-1 KO and WT littermate mice were intraperitoneally injected with 0.5 μg LPS, which is less than the lethal dose for SOCS-1 KO mice (see Figure 6). After 24 hr, these mice were treated with the corresponding lethal doses of LPS (50 μg for SOCS-1 KO mice and 1 mg for WT mice). The lethality was observed until 12 hr after LPS rechallenge. (Ab) Four-week-old SOCS-1 He and WT littermate mice were intraperitoneally injected with 0.5 μg LPS, which is less than the lethal dose for SOCS-1 He mice. After 24 hr, these mice were treated with the corresponding lethal doses of LPS (500 μg for SOCS-1 He mice and 1 mg for WT mice). The lethality was observed until 72 hr after LPS rechallenge. (B) Splenic adherent cells isolated from WT or SOCS-1 KO mice had been incubated with 100 ng/ml LPS (LPS), 50 nM CpG DNA, 3 ng/ml of MALP-2, or only medium (Med) for 24 hr. These cells were subsequently incubated with a second dose of LPS (100 ng/ml) for a further 12 hr, after which culture supernatants were harvested for measurement of TNF-α. (C) Splenic adherent cells were incubated with 100 ng/ml of LPS for the indicated hours, and their SOCS-1 mRNA expression was determined by Northern blotting. (D) Splenic adherent cells from WT or SOCS-1 KO mice had been incubated with 100 ng/ml LPS (LPS) or only medium (Med) for 24 hr. Subsequently, their expression of TLR4/MD-2 was determined by FACS. The proportion of TLR4/MD-2+ cells was shown as a percentage. Geometric mean intensity of TLR4/MD-2 in TLR4/MD-2+ cells was shown in the parentheses. Data in (Aa) and (Ab) represent ten mice in each experimental group and are the result of two independent experiments with similar results. Data in (B) and (D) are representative of three independent experiments with similar results. Immunity 2002 17, 677-687DOI: (10.1016/S1074-7613(02)00449-1)

Figure 4 LPS-Induced SOCS-1 Induction in Macrophages (A) Raw/Neo cells or Raw/SOCS-1 cells were incubated with 2 μg/ml LPS and/or 10 μg/ml IFN-γ for 16 hrs. NO2+NO3 concentration in each supernatant was measured, and the relative fold of nitrite in the supernatant of stimulated cells was calculated to that of unstimulated cells. (B) Raw cells were incubated with 2 μg/ml of LPS for the indicated hours, and their SOCS-1 mRNA expression was determined by RT-PCR. The data are representative of three independent experiments with similar results. Immunity 2002 17, 677-687DOI: (10.1016/S1074-7613(02)00449-1)

Figure 5 SOCS-1 Overexpression Inhibits the LPS Signaling Pathway (A) Both serine 727 and tyrosine 701 phosphorylation of STAT1 was prevented in SOCS-1-transfected Raw cells. Raw cells transfected with (Raw/SOCS-1) or without (Raw/Neo) SOCS-1 construction were incubated with 2 μg/ml LPS for the indicated hours. Whole-cell lysates were used for immunoblotting analysis with anti-phospho Ser727 STAT1 Ab (upper panel) or anti-phospho Tyr701 STAT1 Ab (lower panel). (B) Kupffer cells from WT or MyD88 KO mice were incubated with 2 mg LPS for the indicated hours, and serine phosphorylation (upper) or tyrosine phosphorylation (lower) in each cell lysate was determined by immunoblotting as shown in (A). Immunity 2002 17, 677-687DOI: (10.1016/S1074-7613(02)00449-1)

Figure 6 Partial Involvement of STAT1 in Susceptibility of SOCS-1 KO Mice to LPS In Vivo SOCS-1 KO, SOCS-1/STAT1 DKO, or WT littermate mice were intraperitoneally injected with various amounts of LPS. Lethality was observed at 12 hr after LPS challenge. Five mice in each experimental group were used for this study. The data are representative of two independent experiments with similar results. Immunity 2002 17, 677-687DOI: (10.1016/S1074-7613(02)00449-1)

Figure 7 SOCS-1 Suppressed LPS Induction of NF-κB Reporter Gene Activity by Binding to IRAK (A) Raw cells were transfected with pEF-BOS-SOCS-1 and NF-κB reporter plasmid, p55kB-Luc. Cells were treated with or without various doses of LPS for 3 hr and then luciferase activity was detected. Data are expressed as relative fold activation to that of nonstimulated (−) set. The data are representative of two independent experiments with similar results. (B) COS7 cells were cotransfected with SOCS-1 or various deletion mutants of SOCS-1 and IRAK. After 2 days, cells were lysed and immunoprecipitated with anti-IRAK Ab, and then SOCS-1 was detected by Western blotting. Immunity 2002 17, 677-687DOI: (10.1016/S1074-7613(02)00449-1)